Impact of DPP-4 Inhibitors in Patients with Diabetes Mellitus and Heart Failure: An In-Depth Review

Francisco Epelde, Henrik Falhammar · 2024

Read Impact of DPP-4 Inhibitors in Patients with Diabetes Mellitus and Heart Failure: An In-Depth Review by Francisco Epelde, Henrik Falhammar (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11727843.txt.

Description

The authors review a class of diabetes drugs, the DPP-4 inhibitors, and their safety for patients who also have heart failure. The drugs lower blood sugar well and are usually well tolerated, but trials disagree about the heart. One large trial found more heart-failure hospital stays with one drug of the class, while other trials found neutral effects. The review walks through how the drugs work, how they might touch inflammation, oxidative stress, and scarring in the heart muscle, and what the major trials showed.

Differences between patients, such as heart failure type and other illnesses, may explain part of the conflict. The review also compares rival drug classes that protect the heart more clearly. The authors conclude the drugs remain a valid option for diabetes, but care is needed in advanced heart failure. They call for research that sorts out which patients each drug in the class suits.

Catalog record

CREATORFrancisco Epelde, Henrik Falhammar
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE89 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11727843

Browse the full library · About the Tower of Babel